Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 12, 2026RCTs

Mifepristone improves glycemic control in type 2 diabetes

This study evaluated the effects of mifepristone on glycemic control in type 2 diabetes patients, finding significant improvements in HbA1c levels.

Interventions
Mifepristone
Outcomes
Body weightDiastolic blood pressureFasting Plasma Glucose (FPG)+6 more
Added to Dediabetes Sep 12, 2026RCTs

Remote nurse-led education improves glycemic control in type 2 diabetes

This study evaluated the impact of remote nurse-led patient education on glycemic control in individuals with type 2 diabetes, finding significant improvements in various metabolic markers.

Interventions
Nurse-led diabetic follow-up clinic
Outcomes
Fasting Blood Glucose (FBG)Hemoglobin A1c (HbA1c) with ASTHomeostatic Model Assessment of Beta-cell function (HOMA-β)+2 more
Added to Dediabetes Sep 12, 2026RCTs

Triple therapy may improve glycaemic control in Type 1 Diabetes

This study evaluated the efficacy and safety of adding a GLP-1 receptor agonist and SGLT2 inhibitor to insulin therapy in Type 1 Diabetes, finding significant improvements in HbA1c and quality of life.

Interventions
Dapagliflozin and Semaglutide and InsulinInsulin therapy
Outcomes
Diabetic ketoacidosisFasting blood sugar (FBS)HbA1c+3 more
Added to Dediabetes Sep 12, 2026RCTs

Lifestyle intervention reduces bone turnover in type 2 diabetes

This study investigated the metabolic effects of Metformin and lifestyle modification in early type 2 diabetes management, finding significant benefits from lifestyle changes.

Interventions
Lifestyle intervention for prediabetesMetformin
Outcomes
Anthropometric parametersBody weightChange in plasma levels of Procollagen type 1 N-terminal propeptide (P1NP)+4 more
Added to Dediabetes Sep 12, 2026RCTs

Tirzepatide significantly reduces body weight in Japanese adults with T2D

This study evaluated the efficacy and safety of once-weekly tirzepatide in Japanese participants with obesity and type 2 diabetes, showing significant weight loss compared to placebo.

Interventions
Tirzepatide 10 mg once weeklyTirzepatide 15 mg once weekly
Outcomes
Body weightDiastolic blood pressureFasting Plasma Glucose (FPG)+5 more
Added to Dediabetes Sep 12, 2026RCTs

Mobile health app may improve lifestyle change for diabetes risk

This study evaluated the feasibility of a mobile health app, Plunde, for promoting lifestyle changes in individuals at risk of Type 2 diabetes. It found significant reductions in body weight and waist circumference among app users.

Interventions
Reducing Emotional Distress for Childhood Hypoglycemia in Parents (REDCHiP)
Outcomes
App adherenceApp motivation scoreBody weight+3 more
Added to Dediabetes Sep 12, 2026RCTs

Incretins show little effect on insulin clearance in type 2 diabetes

This randomized controlled trial investigated the effects of incretin-based therapies on insulin clearance in type 2 diabetes. It found significant differences in insulin clearance between treatments.

Interventions
GIPGLP-1 receptor agonistsGLP-1/GIP Combination+3 more
Outcomes
Blood glucoseC-peptideInsulin clearance+4 more
Added to Dediabetes Sep 12, 2026RCTs

GIP receptor activation enhances insulin sensitivity in T2D.

This study investigated the effects of chronic GIP receptor activation on insulin sensitivity in adults with type 2 diabetes, finding significant improvements in insulin metrics.

Interventions
Combination of Macupatide and DulaglutideDulaglutideMacupatide
Outcomes
Disposition IndexGlucose variability parameters M valueInsulin secretion rate (ISR) during GGIT
Added to Dediabetes Sep 12, 2026RCTs

Switching to weekly insulin icodec improves glycemic control

The ONWARDS 10 trial evaluated the switch from daily basal insulin to once-weekly insulin icodec, finding improvements in HbA1c and time in range compared to glargine U100.

Interventions
Glargine U100Once-weekly insulin icodec
Outcomes
Efficacy of Cognitive Behavioral Therapy (CBT) in Diabetes ManagementHbA1cTime in range

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.